Cargando…
Efficacy of finafloxacin in a murine model of inhalational glanders
Burkholderia mallei, the causative agent of glanders, is principally a disease of equines, although it can also infect humans and is categorized by the U.S. Centers for Disease Control and Prevention as a category B biological agent. Human cases of glanders are rare and thus there is limited informa...
Autores principales: | Barnes, Kay B., Bayliss, Marc, Davies, Carwyn, Richards, Mark I., Laws, Thomas R., Vente, Andreas, Harding, Sarah V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730244/ https://www.ncbi.nlm.nih.gov/pubmed/36504783 http://dx.doi.org/10.3389/fmicb.2022.1057202 |
Ejemplares similares
-
Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
por: Barnes, Kay B., et al.
Publicado: (2017) -
The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4
por: Barnes, Kay B., et al.
Publicado: (2019) -
Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection
por: Barnes, Kay B., et al.
Publicado: (2021) -
In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens
por: Harding, Sarah V., et al.
Publicado: (2023) -
Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever
por: Hartley, M. Gill, et al.
Publicado: (2021)